Sunovion Pharmaceuticals Inc.

Sumitomo Pharma Co., Ltd. has decided to cut another 400 employees at its US subsidiary Sumitomo Pharma America, Inc. (SPMA) after already reducing headcount there by 500 in an earlier reorganization

Having delivering a submission for ensifentrine to the desks of US regulators, Verona Pharma plc is now putting in place a strategy designed to give its closely watched chronic obstructive pulmonary

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Daewoong, Vitalli Ink $447m Autoimmune

ImmunoGen, Inc. and Protagonist Therapeutics, Inc. accomplished in early April what has become increasingly difficult for public biotechnology companies to do when they accessed significant amounts